Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

529 results about "Subcutaneous fat" patented technology

Subcutaneous fat is the fatty or adipose tissue lying directly under the skin layers. Subcutaneous translates to "under the skin.". It contains not only fatty tissues but also blood vessels, which supply the skin with oxygen, and nerves. Subcutaneous fat is a shock absorber, helping to cushion our skin against trauma,...

Methods and systems for subcutaneous treatments

Methods for focused remodeling and downsizing the volume of subcutaneous lipid-rich cells, body contouring, and tightening skin tissue, using controlled heating of the targeted areas on the body. The electromagnetic energy heats the. subcutaneous tissues which provides the desired effect. The electromagnetic energy is applied via an applicator without touching the skin. A spacer of insulating or dielectric material may be provided between the applicator and the skin.
Owner:BTL MEDICAL SOLUTIONS AS

Percutaneous cellulite removal system

A percutaneous cellulite removal needle of the present invention can be used to make the appearance of cellulite less obvious by cutting the fibrous bridges that connect the skin to muscle / fascia or fibrous septae in the subcutaneous fat in a minimally invasive manner. The percutaneous cellulite removal needle of the present invention preferably includes a body having an internal chamber that ends at a laterally disposed aperture. A cutting mechanism is substantially positioned within the internal chamber in a retracted position and at least partially protrudes through the laterally disposed aperture in a cutting position. A situating mechanism transitions the cutting mechanism between the retracted position and the cutting position. The present invention also includes a method in which the percutaneous cellulite removal needle is inserted through the skin with the cutting mechanism in the retracted position. The cutting mechanism is then extruded so that the cutting mechanism is in the cutting position. Next the cutting mechanism is actuated, for example by rotating, to cut at least one the fibrous bridge or septae. These steps may be repeated to cut other fibrous bridges or septae reachable by the cutting mechanism. The cutting mechanism is then retracted and the percutaneous cellulite removal needle is removed.
Owner:EXPANDING CONCEPTS

Method of implanting ICD and subcutaneous lead

A subcutaneous implantable cardioverter-defibrillator which has an electrically active canister which houses a source of electrical energy, a capacitor, and operational circuitry that senses the presence of potentially fatal heart rhythms delivers cardioversion defibrillation energy between at least one subcutaneous lead and the electrically active canister. There are no transvenous, intracardiac, or epicardial electrodes. The electrically active canister and at least one lead is implanted utilizing a curved introducer to implant the electrically active canister subcutaneously at various locations around the thorax.
Owner:CAMERON HEALTH

Apparatus and Method for a Combination of Ablative and Nonablative Dermatological Treatment

The invention describes a treatment for skin wherein a pattern of holes is ablated in a selected region of skin tissue using an optical source. Substantially nonablative energy is delivered to the selected region to at least two holes in the pattern to thermally heat a target in or just beneath the skin, such as hair follicles, sebaceous glands, or subcutaneous fat. The invention may further be improved by adding a feedback mechanism that adapts the nonablative energy in response to a measurement enabled by the ablation of holes. The apparatus may include a positional sensor to provide additional dosage control, particularly when the inventive method is used with a continuously movable handpiece.
Owner:RELIANT TECH INC

Methods and devices for manipulating subdermal fat

The present invention features methods of manipulating subdermal fat in a treatment area. Such methods include inserting a needle (e.g., a micro-coring needle) through the dermis to the subdermal fat layer in order to excise a portion of tissue from the treatment area. These insertions result in a portion of the dermis and a portion of subdermal fat to enter into the needle. Removal of the needle results in excision of the portion of dermis and subdermal fat that entered into the needle.
Owner:CYTRELLIS BIOSYST

Method and apparatus for locating and tracking persons

The invention relates to a method and apparatus for locating and tracking persons by use of an implantable device. The described invention is an implant able device composed of biocompatible materials in all areas where contact with organic tissue occurs. The gross anatomic siting of the device includes any limb, the torso, including back and perineum, the neck, and the head. The surgical anatomic siting of the device includes: (1) Supramuscular: for example, deep to the epidermis, dermis, and subcutaneous fat, on or attached to muscle and / or muscle fascia. Such a location is currently used for implantation of commercially available buried intravenous access ports, which are positioned on, and attached to, the pectoralis major muscle fascia; (2) Intramuscular: for example, within or between the muscles of a limb; (3) Submuscular: for example, deep to a large muscle. Such a location is currently used for implantation of commercially available artificial urethral and anal sphincter reservoirs, which are positioned deep to the rectus abdominus muscles, within the pre-peritoneal Space of Retzius; (4) Intraluminal: for example, within the lumen of an organ which has a naturally occurring orifice. Such a location is currently used for implantation of commercially available ingested video endoscopy capsule devices, i.e. gastrointestinal tract lumen, and intrauterine contraceptive devices, i.e. uterus lumen; and (5) Intracavitary: for example, intrathoracic or intraperitoneal. Such an intraperitoneal location is currently used for implantation of commercially available intraperitoneal dialysis catheters.
Owner:PERSEPHONE

Body fat measuring method and device therefor

InactiveUS6978170B1Easily and correctly measuring quantityEasily and correctly measuringSensorsBlood sampling devicesVoltmeterCurrent source
Two current electrodes 2 and 3 are arranged on a circumference of a subject 1, a distance between the two current electrodes being sufficiently shorter than a circumferential length of the subject 1. A current source 4 passes a current between the two current electrodes. A measuring electrode 5 is arranged adjacent to one of the two current electrodes 2 and 3. A measuring electrode 11 is arranged substantially opposite to the two current electrodes 2 and 3 across the subject 1. A voltmeter 7 measures a voltage generated between the measuring electrodes 5 and 11. A body fat computing unit 25 computes the quantity of subcutaneous fat 8 of the subject 1 according to the voltage measured with the voltmeter 7.
Owner:KAO CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products